MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617094498 A) filed by Cullinan Therapeutics, Inc. on August 04, 2026, for Therapies For Autoimmune Disorders.
Inventors include Jones, Jeffrey; Michaelson, Jennifer; Baeuerle, Patrick; Shapiro, Irina; Wax, Stephen; Sreih, Antoine; and Tozzi, Brian.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates methods of producing B cell depletion in autoimmune diseases. More specifically, the invention shows the use of CD-19 bispecific targeting molecules to effectively treat autoimmune disorders such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Sjögren's...